KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Cash from Financing Activities (2017 - 2025)

Cardlytics (CDLX) has disclosed Cash from Financing Activities for 9 consecutive years, with -$6.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 2878.71% year-over-year to -$6.0 million, compared with a TTM value of -$11.1 million through Dec 2025, down 870.22%, and an annual FY2025 reading of -$11.1 million, down 870.22% over the prior year.
  • Cash from Financing Activities was -$6.0 million for Q4 2025 at Cardlytics, down from -$12000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $484.7 million in Q1 2021 and bottomed at -$50.1 million in Q2 2023.
  • Average Cash from Financing Activities over 5 years is $20.8 million, with a median of -$9000.0 recorded in 2022.
  • The sharpest move saw Cash from Financing Activities crashed 5517.89% in 2022, then skyrocketed 16373.08% in 2023.
  • Year by year, Cash from Financing Activities stood at $225000.0 in 2021, then crashed by 179.56% to -$179000.0 in 2022, then surged by 126.82% to $48000.0 in 2023, then tumbled by 520.83% to -$202000.0 in 2024, then crashed by 2878.71% to -$6.0 million in 2025.
  • Business Quant data shows Cash from Financing Activities for CDLX at -$6.0 million in Q4 2025, -$12000.0 in Q3 2025, and -$2.1 million in Q2 2025.